Icon teams with Medidata to access PRO-powering tech

Icon ($ICLR) and Medidata ($MDSO) have teamed up to combine their patient-reported outcome (PRO) capabilities. Medidata is providing the underlying technology, while Icon is contributing its pre-validated surveys. The goal is to make PROs applicable to a wider range of trials and eliminate some of the difficulties sponsors commonly face when adopting the approach. Release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.